Innoviva (INVA) Net Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -863,917.00 |
| Dec 31, 2025 | -1.20 Mn |
| Sep 30, 2025 | 5,160.00 |
| Jun 30, 2025 | -3,383.00 |
| Mar 31, 2025 | -13,574.00 |
| Dec 31, 2024 | -91,384.00 |
| Sep 30, 2024 | -5,919.00 |
| Jun 30, 2024 | -9,359.00 |
| Mar 31, 2024 | 371,972.00 |
| Dec 31, 2023 | -76,078.00 |
| Sep 30, 2023 | 4,564.00 |
| Jun 30, 2023 | 4,919.00 |
| Mar 31, 2023 | 432,355.00 |
| Dec 31, 2022 | -106,667.00 |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | -1,015.00 |
| Mar 31, 2022 | 123,453.00 |
| Dec 31, 2021 | -67,088.00 |
| Sep 30, 2021 | 2,889.00 |
| Jun 30, 2021 | 757,046.00 |
| Mar 31, 2021 | 881,121.00 |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | 6,562.00 |
| Jun 30, 2020 | 17,064.00 |
| Mar 31, 2020 | 23,785.00 |
| Dec 31, 2019 | 27,925.00 |
| Sep 30, 2019 | 218,977.00 |
| Jun 30, 2019 | 686,444.00 |
| Mar 31, 2019 | 874,110.00 |
| Dec 31, 2018 | 371,990.00 |
| Sep 30, 2018 | 1.14 Mn |
| Jun 30, 2018 | 283,702.00 |
| Mar 31, 2018 | 288,250.00 |
| Dec 31, 2017 | 5,879.00 |
| Sep 30, 2017 | 247,487.00 |
| Jun 30, 2017 | 715,753.00 |
| Mar 31, 2017 | -2,564.00 |
| Dec 31, 2016 | 74,952.00 |
| Sep 30, 2016 | 52,136.00 |
| Jun 30, 2016 | 43,695.00 |
| Mar 31, 2016 | 37,638.00 |